Erythromycin (ERY), designated as a risk-prioritized macrolide antibiotic on the 2015 European Union watch list, is the third most commonly used antibiotic, most likely due to its ability to inhibit the protein. ERY has revealed record-high aquatic concentrations threatening the entire ecosystem and hence demands priority remedial measures. The inefficiency of various conventional ERY degradation methodologies opened up a gateway to advanced technologies. The conventional approach comprising of a chemically formulated, single photocatalyst has a major drawback of creating multiple environmental stresses. In this context, photocatalysis is grabbing tremendous attention as an efficient and cost-effective antibiotic treatment approach. Several studies have ascertained that ZnO, TiO